95% of Your PACS Team’s Anonymisation Time Could Be Clinical Time
Every week, a significant portion of your PACS team’s working time disappears into manual anonymisation. It doesn’t appear on a dashboard. It rarely makes it into a budget conversation. But it quietly drains clinical capacity, slows research pipelines, and adds compliance risk that grows with every human touchpoint. BriX reduces that burden by over 95%, returning the time to where it should have been all along.
Where the time is going and why it matters
Anonymisation sits in a blind spot. It doesn’t appear on a dashboard. It doesn’t show up in a budget line. But it’s there, consuming staff hours week after week, hiding in plain sight.
Research shows PACS managers spend up to 30% of their working time on anonymisation tasks alone. For a full-time PACS manager, that’s roughly 12 hours a week, over 600 hours a year, spent on a process that has nothing to do with patient care, diagnostic quality, or strategic work.
That’s not an efficiency problem. That’s a structural one. And structural problems don’t get solved by asking people to work harder.
Every hour spent on manual anonymisation is an hour not spent on improving diagnostic systems, supporting AI research, or reducing the imaging backlog.
The manual process also carries compounding risk. Each human intervention is a potential data handling error: an exposed patient identifier, a missed pixel redaction, a compliance breach that carries serious reputational and regulatory consequences for your institution. No amount of diligence eliminates this risk when the volume is high and the pressure is constant.
What the time drain actually costs your department
The financial case is straightforward once you quantify it. If anonymisation consumes 30% of a PACS manager’s time, a conservative calculation shows:
- Hundreds of consultant-equivalent hours redirected away from clinical and strategic work annually
- Research timelines extended by weeks or months due to data preparation bottlenecks
- AI training datasets that take months to build, when the volume could be processed in days
- Compliance exposure that increases proportionally with manual processing volume
NHS Wales quantified exactly this. Before BriX, their team faced the same structural bottleneck. After implementation, the results were independently verified:
NHS WALES: VERIFIED OUTCOMES WITH BRIX
|
6 Million+ Images anonymised automatically |
567 Working days saved |
450% Return on investment |
567 working days. That’s the equivalent of over two full years of staff time returned to clinical and strategic priorities, from a single deployment.
How BriX works and why the setup time matters
BriX requires 5 minutes of a PACS manager’s time to initiate. A CSV file of studies is uploaded. From that point, BriX runs independently, processing data with speed and accuracy that no manual workflow can match.
|
100 X-Ray studies 4 MINUTES Radiologists redirect to reporting, not file prep |
|
100 CT studies 16 MINUTES AI research datasets ready same day, not next week |
These speeds aren’t marginal improvements on a manual process. They represent a categorical difference, one that makes previously impossible volumes achievable within a standard working day.
A volume of 6,000 studies was processed by one imaging academy in a single week using bulk anonymisation tools. That volume is near-impossible to reach manually. With BriX, it becomes a routine operation.
Compliance isn’t a feature. It’s the foundation.
Manual anonymisation introduces human error at scale. Under pressure, with high volumes, even the most diligent staff will occasionally miss a DICOM header field or fail to catch a pixel-embedded identifier. The consequences (a data breach, a regulatory investigation, reputational damage) are disproportionate to the original error.
BriX applies advanced algorithms to both DICOM headers and pixel data the two layers where patient identifiers can hide. Every study is anonymised to the same standard, every time, with no dependency on individual attention or workload pressure.
Each anonymisation job is fully logged. Every step is traceable and auditable. Governance teams have a complete record without asking for one.
It works inside what you already have
BriX is vendor-neutral. It integrates directly with any PACS or RIS system, clinical trial management platforms, and research archives, without requiring infrastructure changes, system replacements, or extended IT projects.
For NHS trusts navigating complex procurement environments and multi-vendor estates, this matters. There is no rip-and-replace. No retraining. No new system for your team to learn. BriX is additive. It slots into existing workflows and handles the work that your current systems were never designed to do efficiently.
Job scheduling allows anonymisation tasks to be queued and run at specific times, including overnight, further removing the task from active working hours. Multi-profile support means different anonymisation standards (for research, AI training, teaching, or clinical trials) can be applied automatically based on study type.
The case extends beyond PACS management
The implications of bulk anonymisation reach further than operational efficiency. For institutions pursuing AI development, the bottleneck has often been data, not the algorithm. Building a training dataset of sufficient size and diversity manually is a project measured in months. With BriX, it becomes a project measured in days.
The same applies to clinical trial recruitment, multi-site research collaborations, and regional teaching programmes where large volumes of anonymised imaging data are required at speed and scale.
Institutions that remove this bottleneck don’t just save staff time. They unlock programmes that previously weren’t viable.
The question for decision-makers
The case for BriX isn’t built on the promise of a better anonymisation tool. It’s built on a simpler premise: your most skilled staff shouldn’t be spending a third of their working week on a task that automation can handle in minutes.
95% of your PACS team’s anonymisation time is recoverable. The compliance exposure is eliminable. The research pipeline bottleneck is solvable. NHS Wales demonstrated all three, with verified results.
The only question is how long the current situation continues before it’s addressed.